You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...
GoodRx reports 2026 will see higher health insurance premiums, Medicare changes, and many opting out of coverage due to ...
The U.S. Government Patient Assistance Program (USG PAP), operated by Pfizer, will provide eligible Medicare beneficiaries with free Paxlovid access until December 31, 2025. Paxlovid is a prescription ...
The Inflation Reduction Act (IRA) promised big changes for Medicare Part D beneficiaries. Beginning in 2026, patients’ annual out-of-pocket (OOP) costs for Part D drugs are capped at $2,100, and the ...
Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results